GSK Executive and Leadership Team

Heba Elmorshedy, the Chief Financial Officer, Country at GSK, manages the fiscal health and strategic resource allocation for regional operations. Elmorshedy oversees financial planning, budgeting, and risk management processes that support the company's expansive pharmaceutical and biotechnology activities. By providing critical financial insights to the leadership team, the Chief Financial Officer, Country enables data-driven decision-making regarding research investments and commercial expansion. Heba Elmorshedy monitors economic indicators across key markets to ensure financial stability and long-term growth. This role involves maintaining strict adherence to corporate governance standards while optimizing capital efficiency to fund the development of vaccines and specialty medicines. Through rigorous financial oversight, the Chief Financial Officer, Country secures the necessary resources to sustain the company's mission of delivering innovative healthcare solutions, ensuring that regional operations remain aligned with the overarching financial objectives of the global organization.

Redouane Tazi, the Chief Financial Officer (Morocco, Tunisia) at GSK, directs financial strategy and operational accounting within the North African market. Tazi manages local fiscal compliance, tax planning, and investment analysis to support the distribution of vaccines and specialty medicines. By overseeing the financial performance of regional commercial operations, the Chief Financial Officer (Morocco, Tunisia) ensures that resources effectively reach healthcare providers and patients. Redouane Tazi collaborates with global finance teams to align regional reporting with corporate standards, facilitating transparency and accountability. This leadership role involves navigating complex regulatory environments to maintain sustainable growth and profitability. Through strategic financial management, the Chief Financial Officer (Morocco, Tunisia) supports the company's commitment to expanding access to essential treatments, ensuring that the regional business model remains robust, efficient, and capable of meeting the evolving healthcare needs of the population.

Lillian Truesdell, the Chief of Staff To Vice President Finance and Chief Financial Officer US at GSK, coordinates the strategic agenda for the American financial leadership team. Truesdell manages the flow of information between the finance department and executive stakeholders, ensuring alignment on critical fiscal priorities. By facilitating high-level meetings and tracking key performance indicators, the Chief of Staff To Vice President Finance and Chief Financial Officer US enables the leadership to focus on long-term growth and capital allocation. Lillian Truesdell oversees the preparation of financial reports and strategic presentations that guide the company's investment in oncology and HIV research. This role involves streamlining internal processes to enhance the efficiency of the finance function. Through proactive management and clear communication, the Chief of Staff To Vice President Finance and Chief Financial Officer US supports the financial stability required to advance the company's mission in the competitive US pharmaceutical market.

Gregory Naugle, the Site Lead Finance Site Partner & Chief Financial Officer at GSK, directs the financial operations and site-specific fiscal strategy for key manufacturing and research facilities. Naugle oversees the integration of financial planning with operational site requirements, ensuring that production and development activities remain within budgetary constraints. As the Site Lead Finance Site Partner & Chief Financial Officer, Naugle provides essential financial guidance to site leadership, facilitating the efficient allocation of resources for vaccine and medicine manufacturing. Gregory Naugle monitors operational costs and capital expenditures to drive productivity and maintain high standards of quality. This role involves bridging the gap between corporate financial goals and the practical needs of the facility, ensuring that the site contributes effectively to the company's global supply chain. Through strategic financial oversight, the Site Lead Finance Site Partner & Chief Financial Officer supports the continuous delivery of high-quality healthcare products.

Hasham Baber, the Chief Financial Officer & Director, Finance (Pakistan) at GSK, manages the financial integrity and strategic planning for the company's operations in Pakistan. Baber oversees budgeting, financial reporting, and risk management, ensuring that local activities support the global mission of delivering vaccines and specialty medicines. As the Chief Financial Officer & Director, Finance (Pakistan), Baber directs the financial team in maintaining compliance with local regulations and corporate standards. Hasham Baber provides critical analysis of market trends to inform investment decisions and resource allocation within the region. This role involves collaborating with commercial leaders to optimize the supply chain and distribution of essential healthcare products. Through disciplined financial management, the Chief Financial Officer & Director, Finance (Pakistan) ensures the sustainability of the business, enabling the company to continue providing high-quality treatments to patients and healthcare providers throughout the region.

Ronojit Biswas, the Chief Financial Officer (India) & Whole-Time Director at GSK, manages the financial strategy and corporate governance for the company's significant operations in India. Biswas oversees fiscal planning, regulatory compliance, and capital management, ensuring that the regional business remains aligned with global objectives. As the Chief Financial Officer (India) & Whole-Time Director, Biswas provides strategic leadership on the board, guiding the company's investment in research and commercial infrastructure. Ronojit Biswas monitors economic performance and market shifts to optimize the delivery of vaccines and specialty medicines across the region. This role involves maintaining high standards of financial transparency and operational efficiency to support long-term growth. Through rigorous oversight and strategic decision-making, the Chief Financial Officer (India) & Whole-Time Director ensures that the company continues to advance its mission of improving health outcomes for millions of patients in the Indian market.

Penelope Kaltzis, the Chief of Staff, Vaccines at GSK, coordinates high-level operational initiatives across the global vaccine division. Kaltzis manages complex workflows between research teams and commercial departments to accelerate the delivery of life-saving immunizations. By aligning internal resources with the broader mission of addressing infectious diseases, the Chief of Staff, Vaccines ensures that development timelines remain efficient and responsive to global health demands. Penelope Kaltzis facilitates communication between senior leadership and technical staff, fostering a culture of scientific excellence and operational rigor. This role involves monitoring performance metrics across international markets to maintain the company's competitive edge in the pharmaceutical sector. Through meticulous planning and cross-functional collaboration, Kaltzis supports the expansion of the vaccine portfolio, ultimately contributing to the goal of impacting billions of lives through preventative medicine and advanced biotechnology solutions.

Brian Morton, the Manager, Quality System & Chief Marketing Officer, Loc at GSK, directs the integration of rigorous quality standards with localized commercial strategies. Morton oversees the implementation of robust quality management frameworks that ensure compliance across all manufacturing and distribution channels. Simultaneously, the Chief Marketing Officer, Loc designs targeted outreach programs that communicate the value of specialty medicines to healthcare providers and patient groups. Brian Morton bridges the gap between technical quality assurance and market-facing initiatives, ensuring that product integrity remains the foundation of all promotional activities. By analyzing regional market trends, the Chief Marketing Officer, Loc optimizes the positioning of the company's diverse portfolio, ranging from pain relief to complex immunology treatments. This dual-focus leadership role drives operational excellence while expanding the reach of essential healthcare products, reinforcing the company's reputation for reliability and scientific innovation in the global pharmaceutical landscape.

Joyce Bi, the Director, Strategy & Chief of Staff at GSK, architects the long-term strategic vision and coordinates executive operations. Bi identifies emerging market opportunities in the pharmaceutical and biotechnology sectors, providing the leadership team with actionable insights for growth. As the Director, Strategy & Chief of Staff, Bi manages the execution of corporate initiatives, ensuring that departmental goals align with the company's mission to improve global health. Joyce Bi facilitates cross-functional collaboration between research, commercial, and corporate teams to streamline decision-making processes. This role involves analyzing competitive landscapes and internal performance to refine the company's approach to respiratory and immunology therapeutic areas. Through strategic planning and operational oversight, the Director, Strategy & Chief of Staff ensures that the organization remains agile and focused on delivering innovative medicines, ultimately driving the company's impact on patient outcomes across diverse global markets.

Carolyn Grady, the Chief Revenue Officer, Scinovo Management (CMC) at GSK, directs the revenue generation strategies and commercial management for specialized medicine portfolios. Grady oversees the development of pricing models and market access strategies that ensure the widespread availability of innovative treatments. As the Chief Revenue Officer, Scinovo Management (CMC), Grady leads the efforts to maximize the commercial impact of the company's oncology and immunology products. Carolyn Grady collaborates with sales and marketing teams to identify growth opportunities and enhance the value proposition for healthcare systems. This role involves analyzing revenue streams and market dynamics to drive sustainable financial performance. Through strategic leadership, the Chief Revenue Officer, Scinovo Management (CMC) ensures that the company's advanced therapeutic solutions reach the patients who need them most, reinforcing the organization's position as a leader in the global pharmaceutical and biotechnology industry.